APA (7th ed.) Citation

Jeong, H. E., Park, S., Noh, Y., Bea, S., Filion, K. B., Yu, O. H. Y., . . . Shin, J. (2023). Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: A nationwide cohort study. BMC Medicine, 21(1), 1. https://doi.org/10.1186/s12916-023-02765-2

Chicago Style (17th ed.) Citation

Jeong, Han Eol, et al. "Association of Adverse Respiratory Events with Sodium-glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors Among Patients with Type 2 Diabetes in South Korea: A Nationwide Cohort Study." BMC Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12916-023-02765-2.

MLA (9th ed.) Citation

Jeong, Han Eol, et al. "Association of Adverse Respiratory Events with Sodium-glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors Among Patients with Type 2 Diabetes in South Korea: A Nationwide Cohort Study." BMC Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12916-023-02765-2.